Akebia Therapeutics logo

Akebia Therapeutics

A company developing Hypoxia Inducible Factor therapies to treat kidney diseases and other conditions

3

Funding Rounds

$79.0m

Money raised

Overview

A company developing Hypoxia Inducible Factor therapies to treat kidney diseases and other conditions

Funding

Funding series

Funding Series Analysis

The company Akebia Therapeutics has raised a total of $79m in funding over 3 rounds.

Key Insights:

  • Akebia Therapeutics Series C round: $41m
  • Akebia Therapeutics Series B round: $22m
  • Akebia Therapeutics Series A round: $16m
Akebia Therapeutics logo
Akebia Therapeutics Series C round $41m
Akebia Therapeutics logo
Akebia Therapeutics Series B round $22m
Akebia Therapeutics logo
Akebia Therapeutics Series A round $16m

Industries

Akebia Therapeutics is active in the following industries:
  • Therapeutics
  • Technology
  • Biotechnology
  • Healthcare
  • Engineering
  • Biomedical engineering
  • Biology
  • Biopharmaceutical